Biontech Se ADR (BNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 974,445 | 182,860 | 1,370,732 | 4,197,035 | 3,486,121 |
| Cost of Goods | 176,103 | 177,626 | 103,046 | 131,386 | 758,220 |
| Gross Profit | 798,341 | 5,234 | 1,267,685 | 4,065,652 | 2,727,900 |
| Operating Expenses | 718,882 | 620,082 | 565,299 | 835,313 | 323,431 |
| Operating Income | 79,562 | -614,222 | 702,433 | 3,230,722 | 2,404,690 |
| Interest Expense | 2,177 | 1,418 | 31,129 | 1,891 | 4,331 |
| Other Income | 170,117 | 166,177 | 88,341 | -141,600 | 61,339 |
| Pre-tax Income | 247,502 | -449,463 | 759,645 | 3,087,231 | 2,461,698 |
| Income Tax | 72,705 | -241,851 | 220,584 | 875,035 | 663,946 |
| Net Income Continuous | 174,797 | -207,612 | 539,062 | 2,212,197 | 1,797,751 |
| Net Income | $174,797 | $-207,612 | $539,062 | $2,212,197 | $1,797,751 |
| EPS Basic Total Ops | 0.73 | -0.86 | 2.22 | 9.10 | 7.48 |
| EPS Basic Continuous Ops | 0.73 | -0.86 | 2.22 | 9.09 | 7.48 |
| EPS Diluted Total Ops | 0.73 | -0.86 | 2.20 | 9.92 | 7.03 |
| EPS Diluted Continuous Ops | 0.73 | -0.86 | 2.20 | 9.92 | 7.03 |
| EBITDA(a) | $124,386 | $-578,905 | $736,138 | $3,265,652 | $2,434,966 |